Gab2 and MALT1 Influence Regulation of Thromboinflammation, Deep Vein Thrombosis
Researchers conducted an analysis of the Gab2-MALT1 pathway to determine whether it impacts the development of thromboinflammation and deep vein thrombosis.
Diagnosis & Disease Information
Deep Vein Thrombosis, Pulmonary Embolism, and Bleeding Risk in COVID-19
Researchers sought to determine the risk for pulmonary embolism, deep vein thrombosis, and bleeding in patients recovering from COVID-19 infection.
Catheter-Directed Thrombolysis Appears Safe and Effective for Postpartum Deep Venous Thrombosis
Researchers sought to determine whether catheter-directed thrombolysis would be effective in patients with postpartum iliofemoral deep venous thrombosis.
Assessment of Deep Vein Thrombosis Risk With an Artificial Liver Support System
Researchers sought to develop a model to estimate the risk of DVT in patients treated for liver failure using an artificial liver support system.
Bleeding and Thrombotic Risks in Young Patients With Beta-Thalassemia Major
Researchers sought to determine whether pediatric patients with beta-thalassemia major are at increased risk of both bleeding and thrombosis.
Incidence of Bleeding, Thrombotic Complications After CAR-T Therapy
Researchers sought to determine the incidence of bleeding and thrombotic events in patients receiving CAR-T therapy.
COVID-19 Vaccination Does Not Increase Deep Vein Thrombosis Risk
Researchers sought to determine whether vaccination against COVID-19 would increase the risk of developing deep vein thrombosis.
Early Central Venous Catheter Removal and Pulmonary Embolism Risk
Researchers sought to determine whether early central venous catheter removal would be linked to pulmonary embolism risk in patients with catheter-related upper extremity deep vein thrombosis.
Nomogram May Help Predict Deep Vein Thrombosis After Liver Surgery for Patients With Hepatocellular Carcinoma
Researchers sought to determine whether a nomogram may be helpful to predict risk of DVT after laparoscopic hepatectomy in patients with HCC.
Thromboprophylaxis Is Safe and Effective in Patients With High-Risk Cancer
Intermediate anticoagulation doses appear to be safe and effective as thromboprophylaxis in patients with high thrombotic risk active cancer.
- Loading...
Loading...
Next post in ESMO 2021
Loading... 
Loading...